Archive
Home / Media Centre / Archive
Here you can find the archive of all Press Releases prior to 2022
Filter by date:
Showing 1107 press releases before 2022
-
AstraZeneca to present data on next generation of biologics at European Respiratory Society International Congress 2017
-
AstraZeneca highlights latest advances in lung cancer at the ESMO 2017 Congress
-
AstraZeneca and Takeda establish collaboration to develop and commercialise MEDI1341 for Parkinson’s disease
-
Faslodex receives US FDA approval as monotherapy for expanded use in breast cancer
-
Extended treatment with Brilinta reduces risk of cardiovascular death by 29% in patients with history of heart attack
-
Lynparza receives additional and broad approval in the US for ovarian cancer
-
US FDA accepts regulatory submission for acalabrutinib and grants Priority Review
-
Acalabrutinib granted Breakthrough Therapy Designation by US FDA for the treatment of patients with mantle cell lymphoma
-
Imfinzi granted Breakthrough Therapy Designation by US FDA for patients with locally-advanced unresectable non-small cell lung cancer
-
Tagrisso significantly improves progression-free survival in the Phase III FLAURA trial for lung cancer
Latest articles and press releases
All of our latest press releases and articles are available to explore
